Advance Biomaterial Company Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-06-2024
- Paid Up Capital ₹ 0.10 M
as on 17-06-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 6.81%
(FY 2022)
- Profit -38.70%
(FY 2022)
- Ebitda -41.97%
(FY 2022)
- Net Worth 26.84%
(FY 2022)
- Total Assets 8.26%
(FY 2022)
About Advance Biomaterial Company
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hitesh Sanghavi and Hetika Sanghavi serve as directors at the Company.
- CIN/LLPIN
U25209GJ2012PTC070516
- Company No.
070516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2012
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Advance Biomaterial Company Private Limited offer?
Advance Biomaterial Company Private Limited offers a wide range of products and services, including Disposable Cutlery and Crockery, Disposable Glasses, Packaging, Laminated & Zip Bags, Biodegradable and Compostable Bags, Eco Friendly Disposable Plates, PET Granules & Plastic Raw Material, Plastic Polymers, Biodegradable Additives, Disposable Cutlery.
Who are the key members and board of directors at Advance Biomaterial Company?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Sanghavi  | Director | 01-Jul-2013 | Current |
| Hetika Sanghavi | Director | 01-Jul-2013 | Current |
Financial Performance of Advance Biomaterial Company.
Advance Biomaterial Company Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.81% increase. The company also saw a substantial fall in profitability, with a 38.7% decrease in profit. The company's net worth Soared by an impressive increase of 26.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advance Biomaterial Company?
In 2022, Advance Biomaterial Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advance Biomaterial Company?
Unlock and access historical data on people associated with Advance Biomaterial Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advance Biomaterial Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advance Biomaterial Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
